Abstract:Citrobacter koseri (C. koseri) is a Gram-negative bacterium that can cause a highly aggressive form of neonatal meningitis, which often progresses to establish multi-focal brain abscesses. The roles of Toll-like receptor 4 (TLR4) and its signaling adaptor MyD88 during CNS C. koseri infection have not yet been examined, which is important since recent evidence indicates that innate immune responses are tailored towards specific pathogen classes. Here TLR4 WT (C3H/FeJ) and TLR4 mutant (C3H/HeJ) mice as well as MyD88 KO animals were infected intracerebrally with live C. koseri, resulting in meningitis and ventriculitis with accompanying brain abscess formation. MyD88 KO mice were exquisitely sensitive to C. koseri, demonstrating enhanced mortality rates and significantly elevated bacterial burdens compared to WT animals. Interestingly, although early proinflammatory mediator release (i.e. 12 h) was MyD88-dependent, a role for MyD88-independent signaling was evident at 24 h, revealing a compensatory response to CNS C. koseri infection. In contrast, TLR4 did not significantly impact bacterial burdens or proinflammatory mediator production in response to C. koseri. Similar findings were obtained with primary astrocytes, where MyD88-dependent pathways were essential for chemokine release in response to intact C. koseri, whereas TLR4 was dispensable; implicating the involvement of alternative TLRs since highly enriched astrocytes did not produce IL-1 upon bacterial exposure, which also signals via MyD88. Collectively, these findings demonstrate the importance of MyD88-dependent mechanisms in eliciting maximal proinflammatory responses, astrocyte activation, and bacterial containment during CNS C. koseri infection, as well as a late-phase MyD88-independent signaling pathway for cytokine/chemokine production.

Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis

TLR9 and its signaling pathway in multiple sclerosis

TLR Signaling Adaptor Protein MyD88 in Primary Sensory Neurons Contributes to Persistent Inflammatory and Neuropathic Pain and Neuroinflammation

Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems

Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis.

TLR2 Stimulation Regulates the Balance Between Regulatory T Cell and Th17 Function: a Novel Mechanism of Reduced Regulatory T Cell Function in Multiple Sclerosis.

Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics

Role of Follicular CD8+ T Cells Labeled with B Cell Helper Immunotypes in Multiple Sclerosis and a Murine Model

Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis

The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis

Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis

Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis

Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis

Anti-inflammatory Mechanisms of IFN-γ Studied in Experimental Autoimmune Encephalomyelitis Reveal Neutrophils As a Potential Target in Multiple Sclerosis.

T cells in the pathogenesis of multiple sclerosis and related therapy

TPL2 Mediates Autoimmune Inflammation Through Activation of the TAK1 Axis of IL-17 Signaling

MyD88 is Pivotal for Immune Recognition of Citrobacter Koseri and Astrocyte Activation During CNS Infection†

Oligodendroglial precursors orchestrate immune network instigating early demyelination in experimental autoimmune encephalomyelitis

Involvement of Toll Like Receptor 2 Signaling in Secondary Injury During Experimental Diffuse Axonal Injury in Rats

Progress of Signaling Pathways Abnormal in Multiple Sclerosis